MRC-Holland MLPA. Description version 14; 28 September 2016

Similar documents
MRC-Holland MLPA. Description version 08; 30 March 2015

MRC-Holland MLPA. Description version 12; 13 January 2017

SALSA MLPA probemix P169-C2 HIRSCHSPRUNG-1 Lot C As compared to version C1 (lot C1-0612), the length of one probe has been adjusted.

SALSA MLPA probemix P241-D2 MODY mix 1 Lot D As compared to version D1 (lot D1-0911), one reference probe has been replaced.

MRC-Holland MLPA. Description version 07; 26 November 2015

MRC-Holland MLPA. Description version 30; 06 June 2017

MRC-Holland MLPA. Description version 29; 31 July 2015

SALSA MLPA probemix P241-D2 MODY mix 1 Lot D2-0716, D As compared to version D1 (lot D1-0911), one reference probe has been replaced.

MRC-Holland MLPA. Description version 18; 09 September 2015

MRC-Holland MLPA. Description version 08; 18 November 2016

SALSA MLPA probemix P315-B1 EGFR

MRC-Holland MLPA. Description version 08; 07 May 2015

SALSA MLPA probemix P185-C2 Intersex Lot C2-1015: As compared to the previous version C1 (lot C1-0611), the lengths of four probes have been adjusted.

Most severely affected will be the probe for exon 15. Please keep an eye on the D-fragments (especially the 96 nt fragment).

MRC-Holland MLPA. Description version 06; 23 December 2016

P323-B1 CDK4-HMGA2-MDM2

SALSA MLPA probemix P372-B1 Microdeletion Syndromes 6 Lot B1-1016, B

New: P077 BRCA2. This new probemix can be used to confirm results obtained with P045 BRCA2 probemix.

SALSA MLPA probemix P371-A1 Microdeletion Syndromes 5 Lot A1-0509

MRC-Holland MLPA. Description version 06; 07 August 2015

SALSA MLPA KIT P050-B2 CAH

MRC-Holland MLPA. Related SALSA MLPA probemixes P190 CHEK2: Breast cancer susceptibility, genes included: CHEK2, ATM, PTEN, TP53.

MRC-Holland MLPA. Description version 19;

MRC-Holland MLPA. Description version 29;

MRC-Holland MLPA. Description version 13;

SALSA MLPA probemix P360-A1 Y-Chromosome Microdeletions Lot A

SALSA MLPA KIT P060-B2 SMA

SALSA MS-MLPA KIT ME011-A1 Mismatch Repair genes (MMR) Lot 0609, 0408, 0807, 0407

SALSA MLPA probemix P383-A1 T-ALL Lot A

SALSA MLPA KIT P078-B1 Breast Tumour Lot 0210, 0109

SALSA MLPA Probemix P014-B1 Chromosome 8 Lot B and B

MRC-Holland MLPA. Description version 52; 22 July 2015

MRC-Holland MLPA. Description version 23; 15 February 2018

PRADER WILLI/ANGELMAN

SALSA MLPA probemix P175-A3 Tumour Gain Lot A3-0714: As compared to the previous version A2 (lot A2-0411), nine probes have a small change in length.

MRC-Holland MLPA. Description version 05; 03 April 2019

MRC-Holland MLPA. Description version 28; 4 January 2018

Product Description SALSA MLPA Probemix P055-D1 PAH To be used with the MLPA General Protocol.

MRC-Holland MLPA. Description version 23; 26 January 2017

Product Description SALSA MLPA probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol.

MRC-Holland MLPA. Description version 10; 06 April 2018

Product Description SALSA MLPA Probemix P138-C1 SLC2A1-STXBP1 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P027-C2 Uveal melanoma To be used with the MLPA General Protocol.

Product Description SALSA MS-MLPA Probemix ME028-C1 Prader-Willi/Angelman To be used with the MS-MLPA General Protocol.

MRC-Holland MLPA. Description version 15;

Product Description SALSA MLPA Probemix P045-C1 BRCA2/CHEK2 To be used with the MLPA General Protocol.

Product Description SALSA MS-MLPA Probemix ME011-C1 Mismatch Repair Genes To be used with the MS-MLPA General Protocol.

SALSA MLPA KIT P036-E1 HUMAN TELOMERE-3 Lot 0808: As compared to the previous version (P036-D2), the probes for 1p and 4q have been replaced.

Product Description SALSA MLPA Probemix P015-F2 MECP2 To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P002-D1 BRCA1 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P002-D1 BRCA1 To be used with the MLPA General Protocol.

Sharan Goobie, MD, MSc, FRCPC

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction

Supplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our

JULY 21, Genetics 101: SCN1A. Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology

MRC-Holland MLPA. Description version 24;

Product Description SALSA MLPA Probemix P250-B2 DiGeorge To be used with the MLPA General Protocol.

For in vitro Veterinary Diagnostics only. Kylt Rotavirus A. Real-Time RT-PCR Detection.

Certificate of Analysis

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

MODULE NO.14: Y-Chromosome Testing

Corporate Medical Policy

This is DUE: Come prepared to share your findings with your group.

Breast cancer. Risk factors you cannot change include: Treatment Plan Selection. Inferring Transcriptional Module from Breast Cancer Profile Data

Product Description SALSA MLPA Probemix P064-C2 Microdeletion Syndromes-1B To be used with the MLPA General Protocol.

Epigenetics and Chromatin Remodeling

Muscular Dystrophy. Biol 405 Molecular Medicine

SUPPLEMENTARY INFORMATION

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

Haemoglobinopathies case studies 11 th Annual Sickle Cell and Thalassaemia Conference October 2017

Functional insights from genetic channelopathies Stephanie Schorge

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

(SMN1), which is found in the lower part of the spinal cord. 1 There are several different types of

Comprehensive Hemoglobin Analysis HBA1/2 (

Issues arising from UKNEQAS schemes. Ottie O Brien, Northern Genetics Service, Newcastle, UK 15 th May 2014

Cytogenetics 101: Clinical Research and Molecular Genetic Technologies

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014

CHROMOSOMAL MICROARRAY (CGH+SNP)

Next Generation Sequencing as a tool for breakpoint analysis in rearrangements of the globin-gene clusters

Annotation of Chimp Chunk 2-10 Jerome M Molleston 5/4/2009

An Unexpected Function of the Prader-Willi Syndrome Imprinting Center in Maternal Imprinting in Mice

MEDICAL GENOMICS LABORATORY. Peripheral Nerve Sheath Tumor Panel by Next-Gen Sequencing (PNT-NG)

CYP21A2 Mutations Found in Congenital Adrenal Hyperplasia Patients in the California Population

Neurotransmitter Systems II Receptors. Reading: BCP Chapter 6

Differentiation-induced Changes of Mediterranean Fever Gene (MEFV) Expression in HL-60 Cell

Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns

Detection of copy number variations in PCR-enriched targeted sequencing data

READ ORPHA.NET WEBSITE ABOUT BETA-SARCOGLYOCANOPATHY LIMB-GIRDLE MUSCULAR DYSTROPHIES

A novel isothermal amplification approach for rapid identification of BCR-ABL fusion genes at onset:

No mutations were identified.

Association of motor milestones and SMN2 copy and outcome in spinal muscular. atrophy types 0 4

Multi-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi

Reporting TP53 gene analysis results in CLL

Table S1. Primers and PCR protocols for mutation screening of MN1, NF2, KREMEN1 and ZNRF3.

2/7/16. Neurons maintain a negative membrane potential. Membrane potential. Ion conductances determine the membrane potential

Exosome DNA Extraction Kits

Voltage Gated Ion Channels

Lynch Syndrome and COLARIS Testing

Transcription:

SALSA MLPA probemix P279-B3 CACNA1A Lot B3-0816. As compared to version B2 (lot B2-1012), one reference probe has been replaced and the length of several probes has been adjusted. Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release and gene expression. Calcium channels are multi-subunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit whereas the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1a, B, C, D, E, and S. The CACNA1A gene encodes the alpha-1a subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with two neurological disorders, familial hemiplegic migraine and episodic ataxia 2. Episodic ataxia 1 is caused by mutations in the KCNA1 gene. The CACNA1A gene (47 exons) spans ~300 kb of genomic DNA and is located on 19p13.2, 13.3 Mb from the p-telomere. The P279-B3 CACNA1A probemix contains probes for 30 of the 47 exons of the CACNA1A gene (two probes for exon 1). Furthermore one flanking probe located 2 Mb downstream of CACNA1A has been included. KCNA1 (2 exons) spans ~8.4 kb of genomic DNA and is located on 12p13.32, 4.9 Mb from the p- telomere. Probes for both exons are included. In addition, the P279 probemix contains 11 reference probes detecting several different autosomal chromosomal locations. This SALSA probemix is designed to detect deletions/duplications of one or more sequences in the aforementioned gene(s) in a DNA sample. Heterozygous deletions of recognition sequences should give a 35-50% reduced relative peak height of the amplification product of that probe. Note that a mutation or polymorphism in the sequence detected by a probe can also cause a reduction in relative peak height, even when not located exactly on the ligation site! In addition, some probe signals are more sensitive to sample purity and small changes in experimental conditions. Therefore, deletions and duplications detected by MLPA should always be confirmed by other methods. Not all deletions and duplications detected by MLPA will be pathogenic; users should always verify the latest scientific literature when interpreting their findings. We have no information on what percentage of defects in these genes is caused by deletions/duplications of complete exons. Finally, note that most defects in this gene are expected to be small (point) mutations which will not be detected by this SALSA test. SALSA probemixes and reagents are sold by for research purposes and to demonstrate the possibilities of the MLPA technique. They are not CE/FDA certified for use in diagnostic procedures. Purchase of the SALSA test probemixes and reagents includes a limited license to use these products for research purposes. The use of a SALSA probemix and reagents requires a thermocycler with heated lid and sequence type electrophoresis equipment. Different fluorescent PCR primers are available. The MLPA technique has been first described in Nucleic Acid Research 30, e57 (2002). Related SALSA probemixes P348 ATP1A2-CACNA1A: Contains 17 more probes for the CACNA1A gene, as well as probes for most ATP1A2 exons. All CACNA1A probes in P348 are different from the probes included in P279. More information Website : www.mlpa.com E-mail : info@mlpa.com (information & technical questions); order@mlpa.com (for orders) Mail : bv; Willem Schoutenstraat 1, 1057 DL Amsterdam, the Netherlands SALSA P279 CACNA1A probemix Page 1 of 6

References Vila-Pueyo M. et al., 2014. A loss-of-function CACNA1A mutation causing benign paroxysmal torticollis of infancy. Europ J Paediatr Neurol. 18:430-433. Carreño O. et al., 2013. Screening of CACNA1A and ATP1A2 genes in hemiplegic migraine: clinical, genetic, and functional studies. Mol Genet Genomic Med. 1:206-222. Kipfer S. et al., 2013. Novel CACNA1A mutation(s) associated with slow saccade velocities. J Neurol. 260:3010-3014. Wan J. et al., 2011. Large genomic deletions in CACNA1A cause episodic ataxia type 2. Front Neurol. 2:51. Labrum R.W. et al., 2009. Large-scale calcium gene rearrangements in episodic ataxia and hemiplegic migraine: implications for diagnostic testing. J Med Genet. 46:786-791. Data analysis The P279-B3 CACNA1A probemix contains 45 MLPA probes with amplification products between 130 and 494 nt. In addition, it contains 9 control fragments generating an amplification product smaller than 120 nt: four DNA Quantity fragments (Q-fragments) at 64-70-76-82 nt, three DNA Denaturation control fragments (Dfragments) at 88-92-96 nt, one X-fragment at 100 nt and one Y-fragment at 105 nt. More information on how to interpret observations on these control fragments can be found in the MLPA protocol. Data generated by this probemix can first be normalised intra-sample by dividing the peak height of each probe s amplification product by the total peak height of only the reference probes in this probemix (block normalisation). Secondly, inter-sample normalisation can be achieved by dividing the intra-normalised probe ratio in a sample by the average intra-normalised probe ratio of all reference samples. Please note that this type of normalisation assumes no changes occurred in the genomic regions recognised by the reference probes. Data normalisation should be performed within one experiment. Only samples purified by the same method should be compared. Confirmation of most exons deletions and amplifications can be done by e.g. Southern blotting, long range PCR, qpcr, FISH. Note that Coffalyser, the MLPA analysis tool developed at, can be downloaded free of charge from our website www.mlpa.com. Many copy number alterations in healthy individuals are described in the database of genomic variants: http://dgv.tcag.ca/dgv/app/home. For example, a duplication of a complete gene might not be pathogenic, while a partial duplication or a deletion may result in disease. For some genes, certain in-frame deletions may result in a very mild, or no disease. Copy number changes of reference probes are unlikely to be the cause of the condition tested for. Users should always verify the latest scientific literature when interpreting their findings. This probemix was developed by R. Vijzelaar at. In case the results obtained with this probemix lead to a scientific publication, it would be very much appreciated if the probemix designer could be included as a co-author. Info/remarks/suggestions for improvement: info@mlpa.com. SALSA P279 CACNA1A probemix Page 2 of 6

Table 1. SALSA MLPA P279-B3 CACNA1A probemix Length Chromosomal position SALSA MLPA probe (nt) reference KCNA1 CACNA1A 64-70-76-82 Q-fragments: DNA quantity; only visible with less than 100 ng sample DNA 88-92-96 D-fragments: Low signal of 88 or 96 nt fragment indicates incomplete denaturation 100 X-fragment: Specific for the X chromosome 105 Y-fragment: Specific for the Y chromosome 130 Reference probe 00797-L00463 5q31 136 CACNA1A probe 09067-L09236 Exon 16 142 CACNA1A probe 13532-L29524 Exon 19 148 «CACNA1A probe 09082-L29525 Exon 43 154 * Reference probe 19447-L25861 14q31 160 CACNA1A probe 09074-L09243 Exon 27 166 CACNA1A probe 09079-L09248 Exon 38 172 CACNA1A probe 13533-L14993 Exon 5 184 CACNA1A probe 09062-L09231 Exon 7 190 CACNA1A probe 09076-L09245 Exon 31 196 Reference probe 05300-L04688 3q11 202 CACNA1A probe 13534-L14994 Exon 2 208 KCNA1 probe 11611-L12371 Exon 1 215 CACNA1A probe 09066-L23736 Exon 13 226 «CACNA1A probe 09080-L09249 Exon 39 232 CACNA1A probe 09063-L09232 Exon 8 241 CACNA1A probe 09072-L23737 Exon 24 251 «CACNA1A probe 09081-L09250 Exon 40 258 CACNA1A probe 09064-L16631 Exon 10 265 «CACNA1A probe 13535-L14995 Exon 42 274 CACNA1A probe 09075-L09244 Exon 29 283 Reference probe 04795-L04170 9q34 292 CACNA1A probe 09059-L09228 Exon 4 301 CACNA1A probe 21111-L29526 Exon 1 310 CACNA1A probe 09065-L09234 Exon 11 319 Reference probe 01017-L00322 18q12 328 CACNA1A probe 21112-L29527 Exon 6 337 CACNA1A probe 09073-L09242 Exon 25 346 CACNA1A probe 09078-L09247 Exon 35 355 KCNA1 probe 11614-L12374 Exon 2 364 Reference probe 10088-L10512 8q22 373 Reference probe 10718-L11300 6p12 382 CACNA1A probe 09068-L09237 Exon 18 391 CACNA1A probe 09056-L09225 Exon 1 400 LDLR probe 03004-L02443 Downstream 409 CACNA1A probe 13537-L14997 Exon 3 416 CACNA1A probe 09070-L09239 Exon 20 427 Reference probe 05561-L04993 7p14 436 CACNA1A probe 09077-L09246 Exon 33 445 «CACNA1A probe 09084-L09253 Exon 47 454 Reference probe 13287-L14620 1p21 463 CACNA1A probe 13538-L14998 Exon 32 475 CACNA1A probe 13539-L14999 Exon 22 485 Reference probe 09870-L10627 2p16 494 Reference probe 06676-L15676 11p15 * New in version B3 (from lot B3-0816 onwards). Changed in version B3 (from lot B3-0816 onwards). Small change in length, no change in sequence detected. «This probe is located within, or close to, a very strong CpG island. A low signal of this probe can be due to incomplete sample DNA denaturation, e.g. due to the presence of salt in the sample DNA. Flanking probe. Included to facilitate the determination of the extent of a deletion/duplication. Copy number alterations of flanking and reference probes are unlikely to be related to the condition tested. SALSA P279 CACNA1A probemix Page 3 of 6

Notes The CACNA1A exon numbering has changed. From description version 14 onwards, we have adopted the NCBI exon numbering that is present in the NM_ sequences for the CACNA1A gene. This exon numbering used here may differ from literature! The exon numbering used in previous versions of this product description can be found between brackets in Table 2. The identity of the genes detected by the reference probes is available on request: info@mlpa.com. Table 2. P279 probes arranged according to chromosomal location Table 2a. CACNA1A gene Length (nt) SALSA MLPA probe CACNA1A exon Ligation site NM_001127221.1 Partial sequence (24 nt adjacent to ligation site) Distance to next probe start codon 237-239 (exon 1) 301 21111-L29526 Exon 1 385-386 GATGTACAAGCA-GTCAATGGCGCA 0.1 kb 391 09056-L09225 Exon 1 503-504 GTGGTGAGAAAA-TACGCCAAAAAG 50.9 kb 202 13534-L14994 Exon 2 13 nt after exon 2 TGAGTGATGTCT-TTTCTCAGGGTC 2.1 kb 409 13537-L14997 Exon 3 662-663 TACTTCATTGGA-ATTTTTTGTTTC 81.2 kb 292 09059-L09228 Exon 4 808-809 GGAGTTTGACCT-ACGGACGCTGAG 6.3 kb 172 13533-L14993 Exon 5 890-891 GTCCTGAAGTCG-ATCATGAAGGCG 5.8 kb 328 21112-L29527 Exon 6 1169-1170 GTGCTGACTGTT-TTCCAGTGCATA 23.7 kb 184 09062-L09231 Exon 7 1215-1216 ACACCCTACAGA-GCAACGATGCCT 1.5 kb 232 09063-L09232 Exon 8 1390-1391 GCAACAACAGAT-TGAACGTGAGCT 4.1 kb 258 09064-L16631 Exon 10 1519-1520 CACCATAAAGAA-AAGCAAGACAGA 13.1 kb 310 09065-L09234 Exon 11 1704-1705 CTCAGGCCTTCT-ACTGGACTGTAC 8.7 kb 215 09066-L23736 Exon 13 1950-1951 GGGCTGTCATAA-AACCTGGCACAT 4.6 kb 136 09067-L09236 Exon 16 2257-2258 GAACGAGGTCAT-GTACGACGGGAT 3.2 kb 382 09068-L09237 Exon 18 2460-2461 TTGCCCTACAGA-AAGCCAAGGAGG 1.3 kb 142 13532-L29524 Exon 19 2580-2581 GGACCAGTGAGA-TGCGAAAGCAGA 12.4 kb 416 09070-L09239 Exon 20 3447-3448 ACAACATGAAGA-ACAACAAGCTGG 3.5 kb 475 13539-L14999 Exon 22 3957-3958 GCCATTACATCC-TGAACCTGCGCT 7.5 kb 241 09072-L23737 Exon 24 4180-4181 CCTCTGGAATAT-TCTCGACTTCAT 13.1 kb 337 09073-L09242 Exon 25 4254-4255 GAAAAGACATCA-ACACGATTAAAT 3.2 kb 160 09074-L09243 Exon 27 4557-4558 AGAAGTATGAAT-TCCATTACGACA 4.5 kb 274 09075-L09244 Exon 29 4944-4945 CGCCTTTCGAGT-ACACGATCATGG 9.9 kb 190 09076-L09245 Exon 31 5111-5112 TTCTAGAATTAT-TTCCGCGATGCC 9.6 kb 463 13538-L14998 Exon 32 (33) 5302-5303 TGTGCAGTCCTT-CAAGGTGAGTCC 0.4 kb 436 09077-L09246 Exon 33 (34) 5341-5342 GATCGCCATGCT-CTTCTTCATCTA 3.4 kb 346 09078-L09247 Exon 35 (36) 5518-5519 TTGGCACAACAT-CATGCTTTCCTG 7.1 kb 166 09079-L09248 Exon 38 (40) 5918-5919 GTCCACTTCAAT-TCCACCCTCATG 10.2 kb 226 «09080-L09249 Exon 39 (41) 6026-6027 ATGATGGCGATT-TGGCCCAATCTG 0.3 kb 251 «09081-L09250 Exon 40 (42) 6124-6125 CATGATGATCAT-GGAGTACTACCG 1.7 kb 265 «13535-L14995 Exon 42 (44) 25 nt before exon 42 GCGCCCACTGCT-ACCCCGGCCTCT 0.4 kb 148 «09082-L29525 Exon 43 (45) 6458-6459 ATGGGCAGAGAT-GGCTACTCCGAC 4.1 kb 445 «09084-L09253 Exon 47 (49b) 7021-7022 TGTAGGGCAGTA-GTTCCGTAAGTG 2088.0 kb stop codon 7020-7022 (exon 47) 400 03004-L02443 LDLR gene TCAGTGCCAACC-GCCTCACAGGTT «This probe is located within, or close to, a very strong CpG island. A low signal of this probe can be due to incomplete sample DNA denaturation, e.g. due to the presence of salt in the sample DNA. Flanking probe. Included to facilitate the determination of the extent of a deletion/duplication. Copy number alterations of flanking and reference probes are unlikely to be related to the condition tested. The NM_001127221.1 sequence represents transcript variant 3 and is a reference standard in the NCBI RefSeqGene project. SALSA P279 CACNA1A probemix Page 4 of 6

Notes The CACNA1A exon numbering has changed. From description version 14 onwards, we have adopted the NCBI exon numbering that is present in the NM_ sequences for the CACNA1A gene. The exon numbering used in previous versions of this product description can be found between brackets in Table 2. Probes for most of the lacking exons of CACNA1A in the P279 probemix are present in the P348 probemix. Table 2b. KCNA1 gene Length (nt) SALSA MLPA probe KCNA1 exon Ligation site NM_000217.2 Partial sequence (24 nt adjacent to ligation site) Distance to next probe start codon 1106-1108 (exon 2) 208 11611-L12371 Exon 1 215-216 GAGAGTGCTGTT-TATCGTCATTTG 4.4 kb 355 11614-L12374 Exon 2 4225-4226 AACTAAACCAAT-TGATTTAATAGT stop codon 2591-2593 (exon 2) The NM_000217.2 sequence is a reference standard in the NCBI RefSeqGene project. Note: Exon numbering used here may differ from literature! Complete probe sequences are available on request: info@mlpa.com. Please notify us of any mistakes: info@mlpa.com. SALSA MLPA probemix P279-B3 CACNA1A sample picture Figure 1. Capillary electrophoresis pattern of a sample of approximately 50 ng human male control DNA analysed with SALSA MLPA probemix P279-B3 CACNA1A (lot B3-0816). SALSA P279 CACNA1A probemix Page 5 of 6

Implemented Changes compared to the previous product description versions. Version 14 28 September 2016 (55) - Product description adapted to a new product version (version number changed, lot number added, small changes in Table 1 and Table 2, new picture included). - Various minor textual changes on pages 1 and 2. - New references added. - Exon numbering of the CACNA1A gene has been changed the Table 1 and Table 2a. Version 13 03 August 2015 (49) - Electropherogram picture(s) using the old MLPA buffer (replaced in December 2012) removed. Version 12 (49) - Product description adapted to a new lot (lot number added, small changes in Table 1 and Table 2, new picture included). Version 11 (48) - Electropherogram pictures using the new MLPA buffer (introduced in December 2012) added. Version 10 (48) - Various minor textual and layout changes. - Remark on RefSeqGene standard and transcript variant added below Table 2. - Small changes of probe lengths in Table 1 and 2 in order to better reflect the true lengths of the amplification products Version 09 (46) - Various minor textual and layout changes. Version 08 (46) - Warning added in Table 2, 373 nt probe 09563-L10017. - Exon numbering of the CACNA1A gene has been changed on page 3 and 4. Version 07 (46) - Added a note about additional probes for CACNA1A gene in the P348 probemix on page 5. - Minor textual changes under Related SALSA MLPA probemixes on page 1. Version 06 (46) - Various minor textual changes on page 1. - Link to the database of genomic variants added to the product description. - Small changes of probe lengths in Table 1 and 2 in order to better reflect the true lengths of the amplification products. SALSA P279 CACNA1A probemix Page 6 of 6